Mizuho Securities Reiterates Buy Rating on Abbvie (ABBV) Following US FTC Clearance Announcement
Tweet Send to a Friend
Mizuho Securities analyst Vamil Divan reiterated a Buy rating and $101.00 price target on Abbvie (NYSE: ABBV) following the company's ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
